These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1950028)

  • 41. Upper gastrointestinal disorders induced by non-steroidal anti-inflammatory drugs.
    Chiba T; Sato K; Endo M; Ando T; Inomata M; Orii S; Suzuki K
    Hepatogastroenterology; 2005; 52(64):1134-8. PubMed ID: 16001646
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nizatidine in therapy and prevention of non-steroidal anti-inflammatory drug-induced gastroduodenal ulcer in rheumatic patients.
    Simon B; Müller P
    Scand J Gastroenterol Suppl; 1994; 206():25-8. PubMed ID: 7863248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of ranitidine on NSAID related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis.
    Van Groenendael JH; Markusse HM; Dijkmans BA; Breedveld FC
    Clin Rheumatol; 1996 Sep; 15(5):450-6. PubMed ID: 8894357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Protection from gastroduodenal adverse effects of acetylsalicylic acid with ranitidine. An endoscopic controlled double-blind study of healthy subjects].
    Müller P; Dammann HG; Bergdolt H; Simon B
    Arzneimittelforschung; 1991 Jun; 41(6):638-9. PubMed ID: 1930353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use?
    Yeomans ND; Svedberg LE; Naesdal J
    Int J Clin Pract; 2006 Nov; 60(11):1401-7. PubMed ID: 17073837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of peptic ulcer induced by non-steroidal anti-inflammatory drugs.
    Malchow-Møller A
    Scand J Gastroenterol Suppl; 1987; 127():87-91. PubMed ID: 3303297
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [75 mg roxatidine nocte protects human gastric mucosa against 300 mg acetylsalicylic acid nocte].
    Simon B; Bergdolt H; Dammann HG; Müller P
    Z Gastroenterol; 1991 Nov; 29(11):599-601. PubMed ID: 1771935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quality of life in arthritis patients using nonsteroidal anti-inflammatory drugs.
    Wiklund I
    Can J Gastroenterol; 1999 Mar; 13(2):129-33. PubMed ID: 10203431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ranitidine in NSAID ulcers.
    Mani V
    Natl Med J India; 1992; 5(2):69. PubMed ID: 1304267
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of ranitidine on gastroduodenal mucosal damage in patients on long-term non-steroidal anti-inflammatory drugs.
    Swift GL; Heneghan M; Williams GT; Williams BD; O'Sullivan MM; Rhodes J
    Digestion; 1989; 44(2):86-94. PubMed ID: 2693162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Why are non-steroidal anti-inflammatory drugs important in peptic ulceration?
    Bianchi Porro G; Pace F; Caruso I
    Aliment Pharmacol Ther; 1987; 1 Suppl 1():540S-547S. PubMed ID: 2979702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-steroidal drug-induced peptic ulceration can we really protect the stomach?
    Sturrock RD
    Br J Rheumatol; 1992 Jul; 31(7):435-6. PubMed ID: 1628163
    [No Abstract]   [Full Text] [Related]  

  • 53. [The prevention of stress-related postoperative and drug-induced erosive-ulcerative lesions of the upper digestive tract].
    Degtiareva II; Khatib Z; Lodianaia EV; Kharchenko NV; Buchnev VI; Nevstruev VP; Piletskiĭ AM; Chervak II
    Lik Sprava; 1995; (3-4):61-4. PubMed ID: 8819924
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastro-duodenal damage due to non-steroidal anti-inflammatory drugs in children.
    Hermaszewski R; Hayllar J; Woo P
    Br J Rheumatol; 1993 Jan; 32(1):69-72. PubMed ID: 8422564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Incidence of acute gastroduodenal lesions in patients with intracranial lesions. Prophylactic value of treatment with ranitidine].
    Soria F; Pérez HR; Mathier VH
    Rev Fac Cien Med Univ Nac Cordoba; 1985; 43(1):32-5. PubMed ID: 3842527
    [No Abstract]   [Full Text] [Related]  

  • 56. The successful medical management of gastric outflow obstruction associated with the use of non-steroidal anti-inflammatory drugs in the elderly.
    Geraghty RJ; Black D; Bruce SA
    Postgrad Med J; 1991 Nov; 67(793):1004-7. PubMed ID: 1775405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prophylaxis with ranitidine against peptic ulcer disease after liver transplantation.
    Klompmaker IJ; Slooff MJ; de Bruijn KM; Sluiter WJ; Bams JL
    Transpl Int; 1988 Dec; 1(4):209-12. PubMed ID: 3075484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term therapy with tolfenamic acid pINN. A clinical and toxicological study with special reference to clinical and chemical laboratory parameters.
    Sørensen K; Christiansen LV
    Scand J Rheumatol Suppl; 1977; (20):1-7. PubMed ID: 305110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use.
    Nash J; Lambert L; Deakin M
    Drugs; 1994 Jun; 47(6):862-71. PubMed ID: 7521828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Ranitidine in the therapy and prevention of NSAR-induced (non-steroidal anti-rheumatic agents) gastroduodenal lesions in patients with rheumatism].
    Simon B; Bergdolt H; Dammann H; Müller P
    Z Gastroenterol; 1991 May; 29(5):217-21. PubMed ID: 1950028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.